Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The pathology of multiple sclerosis: a paradigm shift.

Michael H Barnett1, Ian Sutton

  • 1Brain and Mind Research Institute, University of Sydney, NSW, Australia. mbarnett@mail.usyd.edu.au

Current Opinion in Neurology
|May 17, 2006
PubMed
Summary

Multiple sclerosis (MS) may not start as an autoimmune disease. New research suggests oligodendrocyte apoptosis precedes immune response, driving MS lesion development and injury progression over time.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trial.

BMJ neurology open·2025
Same author

Choroid plexus enlargement in secondary progressive MS: phenotype comparison.

Multiple sclerosis and related disorders·2025
Same author

Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis.

Brain : a journal of neurology·2025
Same author

COVID-19 Vaccine Boosters in People With Multiple Sclerosis: Improved SARS-CoV-2 Cross-Variant Antibody Response and Prediction of Protection.

Neurology(R) neuroimmunology & neuroinflammation·2025
Same author

Choroid Plexus Enlargement in Secondary Progressive MS: phenotype comparison.

medRxiv : the preprint server for health sciences·2025

Area of Science:

  • Neuroimmunology
  • Pathology
  • Multiple Sclerosis Research

Background:

  • Detailed immunopathological assessment of multiple sclerosis (MS) tissue is crucial for understanding disease pathogenesis and injury.
  • Such studies guide cellular/molecular investigations and the development of animal models.

Purpose of the Study:

  • To elucidate the major processes involved in multiple sclerosis pathogenesis and tissue injury.
  • To refine understanding of central nervous system (CNS) immunity and therapeutic targets.

Main Methods:

  • Immunopathological assessment of multiple sclerosis tissue.
  • Analysis of early and late-stage multiple sclerosis lesions.
  • Review of recent pathological findings and their implications.

Related Experiment Videos

Main Results:

  • Early MS lesions suggest oligodendrocyte apoptosis, not primary autoimmune targeting of myelin, initiates the disease.
  • Tissue injury is amplified by subsequent systemic immune response recruitment.
  • Late-stage MS pathology shows a compartmentalized inflammatory response, isolated from systemic influence.

Conclusions:

  • Recent findings raise questions about the etiology of oligodendrocyte apoptosis and inflammatory amplification in MS.
  • Understanding these processes is vital for developing stage-specific therapeutic interventions.
  • Further research is needed on CNS immune regulation and MS pathogenesis.